Mohan Subburaman, Baylink David J, Srivastava Apurva K
Musculoskeletal Disease Center, Loma Linda VA Health Care Systems, Loma Linda, CA 92357, USA.
Bone. 2008 Feb;42(2):388-95. doi: 10.1016/j.bone.2007.10.014. Epub 2007 Oct 28.
We describe a phenotype-driven mutagenesis screen in which mice carrying a targeted mutation are bred with ENU-treated males in order to provide a sensitized system for detecting dominant modifier mutations. The presence of initial mutation renders the screening system more responsive to subtle changes in modifier genes that would not be penetrant in an otherwise wild type background. We utilized two mutant mouse models: 1) mice carrying a mutation in growth hormone releasing hormone receptor (Ghrhr) (denoted 'lit' allele, Ghrhr(lit)), which results in GH deficiency; and 2) mice lacking Smad2 gene, a signal transducer for TGF-beta, an important bone growth factor. The Smad2(-/-) mice are lethal and Ghrhr(lit/lit) mice are dwarf, but both Smad2(+/-) and Ghrhr(lit/)(+) mice exhibit normal growth. We injected 6-7 weeks old C57BL/6J male mice with ENU (100 mg/kg dose) and bred them with Ghrhr(lit/)(+) and Smad2(+/-) mice. The F1 mice with Ghrhr(lit/)(+) or Smad2(+/-) genotype were screened for growth and skeletal phenotypes. An outlier was identified as >3 SD units different from wild type control (n=20-30). We screened about 100 F1 mice with Ghrhr(lit/)(+) and Smad2(+/-) genotypes and identified nine outliers. A backcross established heritability of three mutant lines in multiple generations. Among the phenotypic deviants, we have identified a mutant mouse with 30-40% reduced bone size. The magnitude of the bone size phenotype was amplified by the presence of one copy of the disrupted Ghrhr gene as determined by the 2-way ANOVA (p<0.02 for interaction). Thus, a new mouse model has been established to identify a gene that interacts with GH signaling to regulate bone size. In addition, the sensitized screen also demonstrated higher recovery of skeletal phenotypes as compared to that obtained in the classical ENU screen in wild type mice. The discovery of mutants in a selected pathway will provide a valuable tool to not only to discover novel genes involved in a particular process but will also prove useful for the elucidation of the biology of that process.
我们描述了一种基于表型的诱变筛选方法,即携带靶向突变的小鼠与经ENU处理的雄性小鼠杂交,以提供一个用于检测显性修饰基因突变的敏感系统。初始突变的存在使筛选系统对修饰基因的细微变化更敏感,而这些变化在野生型背景下不会显现。我们使用了两种突变小鼠模型:1)携带生长激素释放激素受体(Ghrhr)突变(称为“lit”等位基因,Ghrhr(lit))的小鼠,该突变导致生长激素缺乏;2)缺乏Smad2基因的小鼠,Smad2是转化生长因子-β(一种重要的骨生长因子)的信号转导分子。Smad2(-/-)小鼠致死,Ghrhr(lit/lit)小鼠矮小,但Smad2(+/-)和Ghrhr(lit/+)小鼠生长正常。我们给6-7周龄的C57BL/6J雄性小鼠注射ENU(剂量为100mg/kg),并将它们与Ghrhr(lit/+)和Smad2(+/-)小鼠杂交。对具有Ghrhr(lit/+)或Smad2(+/-)基因型的F1小鼠进行生长和骨骼表型筛选。将与野生型对照(n=20-30)相差超过3个标准差单位的个体鉴定为异常值。我们筛选了约100只具有Ghrhr(lit/+)和Smad2(+/-)基因型的F1小鼠,鉴定出9个异常值。通过回交确定了三个突变系在多代中的遗传力。在表型异常的个体中,我们鉴定出一只骨尺寸减小30-40%的突变小鼠。通过双向方差分析确定, disrupted Ghrhr基因的一个拷贝的存在放大了骨尺寸表型的程度(交互作用p<0.02)。因此,建立了一种新的小鼠模型来鉴定与生长激素信号相互作用以调节骨尺寸的基因。此外,与野生型小鼠的经典ENU筛选相比,这种敏感筛选还显示出更高的骨骼表型恢复率。在选定途径中发现突变体不仅将为发现参与特定过程的新基因提供有价值的工具,而且对于阐明该过程的生物学特性也将是有用的。